NEW YORK, August 26, 2026, 02:10 - Shares of Richtech Robotics soared 21.6% in response to the company's announcement of a share repurchase plan affecting 2.7% of its outstanding shares.
The rally created 6.6 times more quoted value than the board authorized for purchases.
*Combined Class A and B shares, Sept. 30, 2025 to Aug. 7, 2026.
| Measure | Latest | Prior/comparison | Investor signal |
|---|---|---|---|
| Cash + short-term investments | $362.6M | $251.9M at Sept. 30 | Large funding capacity, largely equity-raised |
| Six-month revenue | $2.57M | $2.42M | +6.1% year over year |
| Six-month RaaS revenue | $0.69M | $0.25M | +181.6%, but still small |
| Six-month operating cash flow | -$2.03M | -$4.94M | Burn improved |
| Combined shares outstanding | 225.10M | 194.59M | +15.7% since Sept. 30 |
| Implied shares at full buyback | 6.09M | At $1.97 | Only 19.9% of recent share increase |
| Company | Market cap | TTM revenue | Price / sales | Aug. 25 move |
|---|---|---|---|---|
| Richtech Robotics (RR) | $0.44B | $0.005B | 82.3× | +21.60% |
| Red Cat (RCAT) | $1.40B | $0.072B | 19.6× | +2.58% |
| Intuitive Surgical (ISRG) | $131.36B | $11.03B | 11.9× | -0.46% |
Peers illustrate scale and valuation dispersion, not direct operational comparability.
1 analyst · Hold
$2.00 target
1.5% above the $1.97 close; $1.99 after hours sat one cent below it.
Next proof points
Actual shares repurchased; new equity issuance; RaaS growth; operating cash use.
The program is discretionary and can be changed or stopped. A full purchase at Tuesday’s price would retire just 2.7% of shares. Further issuance could outweigh it. An 82× trailing-sales valuation increases sensitivity to execution and liquidity shifts.
Sources: Richtech Robotics Aug. 25 repurchase release; Richtech Robotics Form 10-Q for March 31, 2026; StockAnalysis market and financial pages; FinanceCharts volume history; Investing.com analyst poll. Calculations use 225.10 million shares and the Aug. 25 close.
The board authorized purchases of Class B stock through Aug. 21, 2027. No minimum purchase is required. The board may modify, pause or end the program without notice.
| Firm | Action | Rating | Target | Date | Vs. $1.89 |
|---|---|---|---|---|---|
| Freedom Broker | Upgrade | Hold | $2 | Aug. 16, 2026 | +5.8% |
| H.C. Wainwright | Reiterate | Buy | $6 | Feb. 2, 2026 | +217.5% |
Coverage is sparse. The target spread highlights unusually wide uncertainty around commercialization and valuation.
